Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Does The Market Size Of The In Vivo Contract Research Organization Industry Compare Between 2025 And 2029?
The in vivo contract research organization market size has demonstrated strong growth over recent years. It is anticipated to expand from $4.82 billion in 2024 to $5.23 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.5%. This historical growth can be attributed to rising drug development costs, an increasing prevalence of chronic diseases, a boost in pharmaceutical research and development investment, the expansion of biotech startups, and a high demand for novel therapeutics.
The market size for in vivo contract research organizations is projected to experience substantial expansion over the coming years. This sector is anticipated to reach a valuation of $7.19 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.3%. Factors contributing to this anticipated growth include an escalating demand for precision medicine, the worldwide expansion of contract research organization service networks, the emergence of personalized therapeutics, an increasing requirement for translational research, and a rising count of orphan drugs. Key trends expected within this period encompass advanced imaging methods for in vivo models, the implementation of automation in data processing and reporting, the incorporation of omics technologies, the utilization of cloud-based collaboration platforms, and advancements in biologics and biosimilars.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25790&type=smp
Which Major Market Drivers Are Shaping The Future Of The In Vivo Contract Research Organization Market?
An increasing emphasis on personalized medicine is anticipated to fuel the expansion of the in vivo contract research organization market moving ahead. This medical approach involves customizing treatment and preventative measures based on an individual’s genetic composition, lifestyle, and surroundings to achieve optimal health results. The heightened focus on personalized medicine stems from greater access to and lower costs of genomic sequencing technologies. These technological strides facilitate more precise detection of genetic mutations, leading to customized therapies that enhance patient outcomes and minimize experimental approaches in treatment. Consequently, this increased attention on personalized medicine is boosting demand within the in vivo CRO market, given the necessity for bespoke preclinical studies utilizing particular animal models to assess targeted therapies and their impact on unique genetic profiles. As an illustration, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported in February 2024 that the FDA cleared 16 new personalized treatments in 2023, marking an increase from six in 2022. For the fourth consecutive year, personalized medicines constituted over one-third of all novel drug approvals by the U.S. Food and Drug Administration (FDA). Thus, the increasing emphasis on personalized medicine is propelling the growth of the in vivo contract research organization market.
How Is The In Vivo Contract Research Organization Market Classified Into Different Segments?
The in vivo contract research organization market covered in this report is segmented –
1) By Type: Rodent Based, Non-Rodent Based
2) By Type Of Service: Clinical Trial Services, Preclinical Services, Post-Market Services
3) By Good Laboratory Practice Type: Good Laboratory Practice Toxicology, Non Good Laboratory Practice
4) By Applications: Oncology, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Other Applications
5) By End User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Government And Regulatory Bodies
Subsegments:
1) By Rodent-Based: Mice Models, Rat Models, Genetically Engineered Rodents, Immunodeficient Rodents, Humanized Rodents
2) By Non-Rodent-Based: Canine Models, Non-Human Primate Models, Swine Models, Rabbit Models, Zebrafish Models
Which Trends Are Impacting The In Vivo Contract Research Organization Market?
Leading companies within the in vivo contract research organization market are focusing on developing innovative solutions, such as advanced therapy incubator programs, to accelerate the progression of next-generation therapeutics and support early-stage clinical research. An advanced therapy incubator program is a specialized initiative crafted to assist early-stage biotechnology companies by supplying resources, guidance, and infrastructure to hasten the development of advanced therapies, including gene, cell, and RNA-based treatments. As an illustration, in April 2025, Charles River Laboratories International Inc., a US-based pharmaceutical company, initiated its first advanced therapy incubator program cohort. This innovative venture aims to support nascent biotech companies dedicated to advancing next-generation therapies. Participants in the program receive access to Charles River’s scientific knowledge, sophisticated laboratory facilities, and custom in vivo models, which allows them to quickly generate proof-of-concept data. The program furthermore offers a real-world preclinical setting for the validation of therapeutic candidates, contributing to a shorter time-to-clinic and an improved likelihood of regulatory success. This initiative plays a crucial role in progressing the domain of advanced therapies by connecting academic innovations with clinical development.
Who Are The Prominent Global Companies Shaping The In Vivo Contract Research Organization Market?
Major companies operating in the in vivo contract research organization market are Thermo Fisher Scientific Inc., IQVIA Inc., Labcorp Drug Development Inc., ICON plc, Pharmaceutical Product Development LLC, Eurofins Scientific SE, WuXi AppTec, Syneos Health Inc., Charles River Laboratories International Inc., Parexel International Corporation, Evotec SE, GemPharmatech Co Ltd., BIOQUAL Inc., Crown Bioscience Inc., PsychoGenics Inc., Janvier Labs SAS, Taconic Bioscience Inc., Xentech SAS, Pronexus Analytical AB, Altogen Labs Inc., AniLocus Inc.
Download The Full Report For Exclusive Market Findings:
What Are The Regional Market Dynamics Impacting The In Vivo Contract Research Organization Industry?
North America was the largest region in the in vivo contract research organization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo contract research organization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The In Vivo Contract Research Organization Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25790&type=smp
Browse Through More Reports Similar to the Global In Vivo Contract Research Organization Market 2025, By The Business Research Company
Medical Device Contract Research Organization Global Market Report 2025
Biologics Contract Development Global Market Report 2025
Medical Device Contract Manufacturing Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model